144 related articles for article (PubMed ID: 6317238)
21. Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls.
Link H; Olsson O; Sun J; Wang WZ; Andersson G; Ekre HP; Brenner T; Abramsky O; Olsson T
J Clin Invest; 1991 Jun; 87(6):2191-6. PubMed ID: 1904073
[TBL] [Abstract][Full Text] [Related]
22. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
Atassi MZ; Oshima M; Deitiker P
Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
[TBL] [Abstract][Full Text] [Related]
23. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
Duan RS; Adikari SB; Huang YM; Link H; Xiao BG
Neurobiol Dis; 2004 Jul; 16(2):461-7. PubMed ID: 15193302
[TBL] [Abstract][Full Text] [Related]
24. Subpopulations of thyroid autoantibody secreting lymphocytes in Graves' and Hashimoto thyroid glands.
McLachlan SM; Pegg CA; Atherton MC; Middleton SL; Dickinson A; Clark F; Proctor SJ; Proud G; Rees Smith B
Clin Exp Immunol; 1986 Aug; 65(2):319-28. PubMed ID: 3791700
[TBL] [Abstract][Full Text] [Related]
25. Greatly improved recovery of in vitro B-memory cell function after enzymic dispersion of immunized mouse spleens.
Brown AN; Willcox HN
Immunology; 1991 Dec; 74(4):600-5. PubMed ID: 1783419
[TBL] [Abstract][Full Text] [Related]
26. Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis.
Leprince C; Cohen-Kaminsky S; Berrih-Aknin S; Vernet-Der Garabedian B; Treton D; Galanaud P; Richard Y
J Immunol; 1990 Oct; 145(7):2115-22. PubMed ID: 2144544
[TBL] [Abstract][Full Text] [Related]
27. Lymphocyte subpopulations in non-neoplastic thymus from myasthenia gravis patients.
Piantelli M; Musiani P; Lauriola L; Carbone A; Tonali P; Dina MA
Clin Exp Immunol; 1980 Jul; 41(1):19-24. PubMed ID: 6969152
[TBL] [Abstract][Full Text] [Related]
28. Intrathymic Tfh/B Cells Interaction Leads to Ectopic GCs Formation and Anti-AChR Antibody Production: Central Role in Triggering MG Occurrence.
Zhang X; Liu S; Chang T; Xu J; Zhang C; Tian F; Sun Y; Song C; Yi W; Lin H; Li Z; Yang K
Mol Neurobiol; 2016 Jan; 53(1):120-131. PubMed ID: 25407929
[TBL] [Abstract][Full Text] [Related]
29. TCR-Vbeta usage in the thymus and blood of myasthenia gravis patients.
Navaneetham D; Penn AS; Howard JF; Conti-Fine BM
J Autoimmun; 1998 Dec; 11(6):621-33. PubMed ID: 9878084
[TBL] [Abstract][Full Text] [Related]
30. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
Wang ZY; Qiao J; Melms A; Link H
Cell Immunol; 1993 Dec; 152(2):394-404. PubMed ID: 8258147
[TBL] [Abstract][Full Text] [Related]
31. B- and T-cell activation in the thymus of patients with myasthenia gravis.
Cohen-Kaminsky S; Leprince C; Galanaud P; Richards Y; Berrih-Aknin S
Thymus; 1989; 14(1-3):187-93. PubMed ID: 2623739
[TBL] [Abstract][Full Text] [Related]
32. Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor.
Yi HJ; Chae CS; So JS; Tzartos SJ; Souroujon MC; Fuchs S; Im SH
Mol Immunol; 2008 Nov; 46(1):192-201. PubMed ID: 18799218
[TBL] [Abstract][Full Text] [Related]
33. [In vitro immunoglobulin synthesis by peripheral blood mononuclear cells from patients with myasthenia gravis].
Miyazaki Y; Arikawa E; Kubota H; Yagi K; Tanabe H
Rinsho Shinkeigaku; 1990 Jan; 30(1):1-6. PubMed ID: 2331813
[TBL] [Abstract][Full Text] [Related]
34. Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor.
Shiono H; Wong YL; Matthews I; Liu JL; Zhang W; Sims G; Meager A; Beeson D; Vincent A; Willcox N
Int Immunol; 2003 Aug; 15(8):903-13. PubMed ID: 12882828
[TBL] [Abstract][Full Text] [Related]
35. Myasthenia gravis: selective enrichment of antiacetylcholine receptor antibody production in untransformed human B cell cultures.
Padberg F; Matsuda M; Fenk R; Patenge N; Kubuschok B; Hohlfeld R; Wekerle H; Spuler S
Eur J Immunol; 1999 Nov; 29(11):3538-48. PubMed ID: 10556808
[TBL] [Abstract][Full Text] [Related]
36. Diseases of the myoneural junction.
Newsom-Davis J
Res Publ Assoc Res Nerv Ment Dis; 1990; 68():233-40. PubMed ID: 1691520
[TBL] [Abstract][Full Text] [Related]
37. Immunohistological studies of the thymus in myasthenia gravis. Correlation with clinical state and thymocyte culture responses.
Thomas JA; Willcox HN; Newsom-Davis J
J Neuroimmunol; 1982 Dec; 3(4):319-35. PubMed ID: 6757263
[TBL] [Abstract][Full Text] [Related]
38. In vitro synthesis of IgG and antibodies to AChR by peripheral and thymic lymphocytes.
Lisak RP; Levinson AI; Zweiman B; Kornstein MJ
Ann N Y Acad Sci; 1987; 505():39-49. PubMed ID: 3500667
[No Abstract] [Full Text] [Related]
39. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
[TBL] [Abstract][Full Text] [Related]
40. The thymus and myasthenia gravis.
Ragheb S; Lisak RP
Chest Surg Clin N Am; 2001 May; 11(2):311-27, x. PubMed ID: 11413758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
